AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings
About AUTOBIO DIAGNOSTICS CO., LTD
Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 安图生物子公司管理制度（2025年10月修订） | 2025-10-31 | Chinese | |
| 安图生物投资者关系管理制度（2025年10月修订） | 2025-10-31 | Chinese | |
| 安图生物信息披露暂缓与豁免制度（2025年10月制定） | 2025-10-31 | Chinese | |
| 安图生物董事和高级管理人员离职管理制度（2025年10月制定） | 2025-10-31 | Chinese | |
| 安图生物内幕信息知情人登记管理制度（2025年10月修订） | 2025-10-31 | Chinese | |
| 安图生物董事和高级管理人员持有本公司股份及其变动管理制度（2025年10月修订） | 2025-10-31 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 37696309 | 安图生物子公司管理制度（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696307 | 安图生物投资者关系管理制度（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696299 | 安图生物信息披露暂缓与豁免制度（2025年10月制定） | 2025-10-31 | Chinese | ||
| 37696288 | 安图生物董事和高级管理人员离职管理制度（2025年10月制定） | 2025-10-31 | Chinese | ||
| 37696277 | 安图生物内幕信息知情人登记管理制度（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696267 | 安图生物董事和高级管理人员持有本公司股份及其变动管理制度（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696264 | 安图生物对外担保管理制度（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696262 | 安图生物累积投票制实施细则（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696248 | 安图生物重大投资和交易决策制度（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696236 | 安图生物信息披露管理制度（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696224 | 安图生物关联交易管理制度（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696219 | 安图生物外汇套期保值业务管理制度（2025年10月制定） | 2025-10-31 | Chinese | ||
| 37696211 | 安图生物重大事项内部报告制度（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696202 | 安图生物独立董事工作制度（2025年10月修订） | 2025-10-31 | Chinese | ||
| 37696188 | 安图生物接待和推广工作及信息披露备查登记制度（2025年10月修订） | 2025-10-31 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
AUTOBIO DIAGNOSTICS CO., LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57757/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57757 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57757 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57757 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57757}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AUTOBIO DIAGNOSTICS CO., LTD (id: 57757)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.